Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Dirani

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 23, 2020
Treating neovascular age-related macular degeneration in the era of COVID-19Fares Antaki, Ali Dirani
Clinical Ophthalmology (Auckland, N.Z.)|April 12, 2018
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug toleranceAli Dirani, Irmela Mantel
Clinical Ophthalmology (Auckland, N.Z.)|March 22, 2021
Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal InjectionsFares Antaki, Daniel Milad, Ali Dirani
Retina (Philadelphia, Pa.)|July 14, 2015
CONVERSION TO AFLIBERCEPT THERAPY VERSUS CONTINUING WITH RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEPENDENT ON MONTHLY RANIBIZUMAB TREATMENTIrmela Mantel, Christina Gianniou, Ali Dirani
Clinical Ophthalmology (Auckland, N.Z.)|November 9, 2013
Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literatureElias Chelala, Ali Dirani, Ali Fadlallah
Retina (Philadelphia, Pa.)|April 4, 2017
GOOD VISUAL OUTCOME AT 1 YEAR IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PIGMENT EPITHELIUM DETACHMENT: Factors Influencing the Treatment ResponseSophie de Massougnes, Ali Dirani, Irmela Mantel
Nanotechnology|August 12, 2011
Nanopatterning of plasma polymer reactive surfaces by DUV interferometryOlivier Soppera, Ali Dirani, Arnaud Ponche, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 5, 2020
Vitreoretinal Surgery in the Post-Lockdown Era: Making the Case for Combined PhacovitrectomyFares Antaki, Daniel Milad, Simon Javidi, et al.
International Medical Case Reports Journal|June 18, 2020
Displacement of Retained Subretinal Perfluorocarbon Liquid Through Therapeutic Retinal Detachment Induced by Balanced Salt Solution InjectionMarc Saab, Simon Javidi, Ali Dirani, et al.
Retina (Philadelphia, Pa.)|February 5, 2015
REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural OutcomeChristina Gianniou, Ali Dirani, Liuna Jang, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 23, 2020
Treating neovascular age-related macular degeneration in the era of COVID-19Fares Antaki, Ali Dirani
Clinical Ophthalmology (Auckland, N.Z.)|April 12, 2018
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug toleranceAli Dirani, Irmela Mantel
Clinical Ophthalmology (Auckland, N.Z.)|March 22, 2021
Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal InjectionsFares Antaki, Daniel Milad, Ali Dirani
Retina (Philadelphia, Pa.)|July 14, 2015
CONVERSION TO AFLIBERCEPT THERAPY VERSUS CONTINUING WITH RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEPENDENT ON MONTHLY RANIBIZUMAB TREATMENTIrmela Mantel, Christina Gianniou, Ali Dirani
Clinical Ophthalmology (Auckland, N.Z.)|November 9, 2013
Intravitreal anti-VEGF injection for the treatment of progressive juxtapapillary retinal capillary hemangioma: a case report and mini review of the literatureElias Chelala, Ali Dirani, Ali Fadlallah
Retina (Philadelphia, Pa.)|April 4, 2017
GOOD VISUAL OUTCOME AT 1 YEAR IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PIGMENT EPITHELIUM DETACHMENT: Factors Influencing the Treatment ResponseSophie de Massougnes, Ali Dirani, Irmela Mantel
Nanotechnology|August 12, 2011
Nanopatterning of plasma polymer reactive surfaces by DUV interferometryOlivier Soppera, Ali Dirani, Arnaud Ponche, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 5, 2020
Vitreoretinal Surgery in the Post-Lockdown Era: Making the Case for Combined PhacovitrectomyFares Antaki, Daniel Milad, Simon Javidi, et al.
International Medical Case Reports Journal|June 18, 2020
Displacement of Retained Subretinal Perfluorocarbon Liquid Through Therapeutic Retinal Detachment Induced by Balanced Salt Solution InjectionMarc Saab, Simon Javidi, Ali Dirani, et al.
Retina (Philadelphia, Pa.)|February 5, 2015
REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural OutcomeChristina Gianniou, Ali Dirani, Liuna Jang, et al.
Pageof 10